Skip to main content
Premium Trial:

Request an Annual Quote

Bioo Scientific, Qiagen

Premium
Bioo Scientific has recently introduced the RNA-Lancer II, a delivery agent for in vivo RNAi research.
According to the company, the product uses a set of neutral hydrophobic molecules to encapsulate and deliver RNAi agents into tissues for both target validation and therapeutic development applications.
 

 
Qiagen has launched miScript miRNA mimics and miScript miRNA inhibitors.
 
According to the company, the products come ready-to-transfect for use in gene regulation and cellular pathway analysis.
 
The miRNA mimics are synthetic RNA oligonucleotides that function like mature endogenous miRNA molecules when transfected in to mammalian cells and can be used to artificially up-regulate the level of any miRNA in a cell.
 
The inhibitors are synthetic chemically modified RNA oligonucleotides that inhibit endogenously expressed miRNAs. miRNA Inhibitors effectively lower the endogenous levels of miRNA in cells enabling loss-of-function studies.

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.